SCIENTIFIC
CREDIBILITY OF GOVERNMENT PUBLIC HEALTH ADVISORY COMMITTEES
Resolution 123-03
Author: Robert M. Gould, MD
Adopted March 25, 2003
Whereas, a wide variety of federal government agencies with
jurisdiction over public health, as well as state and local
public health agencies, routinely engage scientific advisory
committees and other similar bodies to furnish expert advice,
ideas, recommendations, and diverse opinions to guide agency
policy and decision-making; and,
Whereas, these committees are a core component in ensuring
that the best science is brought to bear to protect the publicís
health, underscoring the importance that members of such scientific
and public health advisory committees be the most qualified
scientists and experts in their fields; and,
Whereas, it is standard ethical practice that candidates
for service on scientific and public health advisory committees
should be free of direct financial conflicts of interest,
and that all such conflicts of interest should be disclosed
to health agencies and the public, so that they can be examined
carefully for potentially disqualifying biases; and,
Whereas, the Federal Advisory Committee Act (FACA) states
that federal advisory committees must be fairly balanced in
terms of the points of view represented,[1] and that such
committees must not be inappropriately influenced by the appointing
authority or by any special interest;[2] and,
Whereas, there are currently no uniform criteria for determining
and managing conflicts of interest or achieving balance on
federal scientific and public health advisory committees,
or for determining the scientific or expert qualifications
of candidates for such committees, and there are also no such
standards for committees at the state and local level; and,
Whereas, federal government officials have recently taken
steps to restructure key scientific and public health advisory
committees by retiring the committees before their work is
completed, removing or failing to reappoint qualified members
and replacing them with less scientifically qualified candidates
and candidates with a clear conflict of interest, and focusing
on the political and ideological leanings of potential panelists
rather than their scientific qualifications, actions that
suggest an effort to inappropriately influence these committees;[3,4,5]
and,
Whereas, in particular, four panels—the Centers for
Disease Control and Prevention’s (CDC) Advisory Committee
to the Director of the National Center for Environmental Health
(NCEH), CDC’s Advisory Committee on Childhood Lead Poisoning
Prevention (ACCLPP), the Food and Drug Administration’s
Reproductive Health Drugs Advisory Committee, and the DHHS’s
National Human Research Protections Advisory Committee (NHRPAC)óare
among the most recent and egregious examples of this effort,
which may lead to decreased federal protections for women,
children, and other vulnerable groups;[6,7,8,9] therefore
be it
RESOLVED: That CMA calls on government officials at all levels
to closely follow the existing guidelines set forth in the
Federal Advisory Committee Act pertaining to the membership
on scientific and public health advisory committees and to
develop more specific criteria related to scientific expertise,
financial disclosure, conflict of interest and diversity;
and be it further
RESOLVED: That CMA should refer this issue for national action.
References
1 Federal Advisory Committee Act, 5 U.S.C.
Appendix 2, ß5(b)(2)
2 Federal Advisory Committee Act, 5 U.S.C.
Appendix 2, ß5(b)(3)
3 HHS Seeks Science Advice to Match Bush Views.
Washington Post. September 17, 2002.
4 Bush's Science Advisors Drawing Criticism.
New York Times. October 9, 2002.
5 Advisors Put Under a Microscope. Los Angeles
Times. December 23, 2002.
6 Michaels, David et al. "Advice without
Dissent." Science. Vol 298, p 703, October 25, 2002.
7 Ferber, Dan. "Critics See a Tilt in
a CDC Science Panel." Science. Vol 297, p 1456-1457,
August 30, 2002.
8 A Report by Markey, Edward J. (Rep D-MA).
Turning Lead into Gold: How the Bush Administration is Poisoning
the Lead Advisory Committee at the CDC. October 8, 2002.
9 "Keeping scientific advice non-partisan"
(editorial). The Lancet. Vol 360, p 1525. November 16, 2002.
|